Henry A Fernandez Msci Inc. (MSCI) insider trading activity

Henry A Fernandez is Chairman and CEO of MSCI Inc.. Currently has a direct ownership of 1.28 Million shares of MSCI, which is worth approximately $704 Million. The most recent transaction as insider was on Jul 25, 2025, when has been sold 84 shares (Common Stock) at a price of $548.1 per share, resulting in proceeds of $46,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.28M

0.79% 3M change

26.66% 12M change

Total Value Held $704 Million

Henry A Fernandez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 25 2025	BUY Open market or private purchase	$46,040 $548.1 p/Share	84 Added 0.01%	1,279,951 Common Stock
Jul 24 2025	BUY Open market or private purchase	$5,401,245 $544.7 p/Share	9,916 Added 0.77%	1,279,867 Common Stock
Feb 24 2025	BUY Open market or private purchase	$3,039,550 $573.5 p/Share	5,300 Added 0.42%	1,269,951 Common Stock
Feb 06 2025	SELL Payment of exercise price or tax liability	$18,963,266 $587.48 p/Share	32,279 Reduced 2.49%	1,264,651 Common Stock
Feb 06 2025	BUY Grant, award, or other acquisition	-	58,370 Added 4.31%	1,296,930 Common Stock
Apr 25 2024	SELL Bona fide gift	-	22,500 Reduced 1.27%	1,745,267 Common Stock
Feb 05 2024	SELL Payment of exercise price or tax liability	$29,461,778 $583.39 p/Share	50,501 Reduced 3.22%	1,516,224 Common Stock
Feb 05 2024	BUY Grant, award, or other acquisition	-	91,320 Added 5.67%	1,520,260 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$8,768,947 $556.9 p/Share	15,746 Reduced 1.27%	1,223,839 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	28,472 Added 2.25%	1,239,585 Common Stock
Feb 07 2022	SELL Payment of exercise price or tax liability	$23,372,108 $550.45 p/Share	42,460 Reduced 3.39%	1,211,113 Common Stock
Feb 07 2022	BUY Grant, award, or other acquisition	-	80,187 Added 6.01%	1,253,573 Common Stock
Dec 21 2021	SELL Bona fide gift	-	11,445 Reduced 0.68%	1,676,495 Common Stock

Also insider at

RPRX

Royalty Pharma plc Healthcare

Director

HAF